Brain, blood, and iron: Perspectives on the roles of erythrocytes and iron in neurodegeneration

[1]  A. Danek,et al.  Mutation in the CHAC gene in a family of autosomal dominant chorea–acanthocytosis , 2012, Neurology.

[2]  Hans H. Jung,et al.  McLeod neuroacanthocytosis syndrome , 2012 .

[3]  J. Hardy,et al.  Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations , 2012, Neurobiology of Aging.

[4]  M. Mahajan,et al.  Genetic diagnosis of neuroacanthocytosis disorders using exome sequencing , 2012, Movement disorders : official journal of the Movement Disorder Society.

[5]  S. Schneider,et al.  Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation , 2012, American Journal of Neuroradiology.

[6]  Christopher A Ross,et al.  Loss of junctophilin‐3 contributes to huntington disease‐like 2 pathogenesis , 2012, Annals of neurology.

[7]  S. Schneider,et al.  Chorea-acanthocytosis , 2012, Journal of the Neurological Sciences.

[8]  L. Schöls,et al.  Chorein‐sensitive polymerization of cortical actin and suicidal cell death in chorea‐acanthocytosis , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  A. Danek,et al.  Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. , 2011, Blood.

[10]  M. Elstner,et al.  Absence of an orphan mitochondrial protein, c19orf12, causes a distinct clinical subtype of neurodegeneration with brain iron accumulation. , 2011, American journal of human genetics.

[11]  D. Chu,et al.  Genetic and functional analyses describe a novel 730delG mutation in the KEL gene causing K0 phenotype in a Taiwanese blood donor , 2011, Transfusion medicine.

[12]  T. Rouault,et al.  Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts. , 2011, Blood.

[13]  Hans H. Jung,et al.  Feeding dystonia in McLeod Syndrome , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  R. Margolis,et al.  A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression. , 2011, Human molecular genetics.

[15]  D. Horn,et al.  Cohen Syndrome-associated Protein, COH1, Is a Novel, Giant Golgi Matrix Protein Required for Golgi Integrity* , 2011, The Journal of Biological Chemistry.

[16]  W. Oertel,et al.  The PLA2G6 gene in early‐onset Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[17]  E. Stack,et al.  Retromer disruption promotes amyloidogenic APP processing , 2011, Neurobiology of Disease.

[18]  P. Cullen,et al.  Recent Advances in Retromer Biology , 2011, Traffic.

[19]  S. Grinstein,et al.  High-resolution mapping reveals topologically distinct cellular pools of phosphatidylserine , 2011, The Journal of cell biology.

[20]  L. Klobutcher,et al.  Vacuolar Protein Sorting Protein 13A, TtVPS13A, Localizes to the Tetrahymena thermophila Phagosome Membrane and Is Required for Efficient Phagocytosis , 2011, Eukaryotic Cell.

[21]  M. Farrer,et al.  VPS35 mutations in Parkinson disease. , 2011, American journal of human genetics.

[22]  Marc N. Offman,et al.  A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease. , 2011, American journal of human genetics.

[23]  Ai Yamamoto,et al.  The elimination of accumulated and aggregated proteins: A role for aggrephagy in neurodegeneration , 2011, Neurobiology of Disease.

[24]  A. Spada,et al.  Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging , 2011, Neurobiology of Disease.

[25]  P. Burbaud,et al.  Head drops are also observed in McLeod syndrome , 2011, Movement disorders : official journal of the Movement Disorder Society.

[26]  A. Cuervo,et al.  Chaperone-mediated autophagy dysfunction in the pathogenesis of neurodegeneration , 2011, Neurobiology of Disease.

[27]  S. Sunkin,et al.  CTCF Regulates Ataxin-7 Expression through Promotion of a Convergently Transcribed, Antisense Noncoding RNA , 2011, Neuron.

[28]  J. Nunnari,et al.  Mitochondria regulate autophagy by conserved signalling pathways , 2011, The EMBO journal.

[29]  A. Wilton,et al.  A canine model of Cohen syndrome: Trapped Neutrophil Syndrome , 2011, BMC Genomics.

[30]  Dobrila D. Rudnicki,et al.  An Antisense CAG Repeat Transcript at JPH3 Locus Mediates Expanded Polyglutamine Protein Toxicity in Huntington's Disease-like 2 Mice , 2011, Neuron.

[31]  N. Mohandas,et al.  Phosphorylation-dependent perturbations of the 4.1R-associated multiprotein complex of the erythrocyte membrane. , 2011, Biochemistry.

[32]  P. Ney.  Normal and disordered reticulocyte maturation , 2011, Current opinion in hematology.

[33]  R. Walker.  Differential Diagnosis of Chorea , 2011, Current neurology and neuroscience reports.

[34]  G. Kroemer,et al.  Autophagy for tissue homeostasis and neuroprotection. , 2011, Current opinion in cell biology.

[35]  M. Grafe,et al.  Novel histopathologic findings in molecularly-confirmed pantothenate kinase-associated neurodegeneration. , 2011, Brain : a journal of neurology.

[36]  J. Bonifacino,et al.  Transport according to GARP: receiving retrograde cargo at the trans-Golgi network. , 2011, Trends in cell biology.

[37]  A. Gregory,et al.  Genetics of Neurodegeneration with Brain Iron Accumulation , 2011, Current neurology and neuroscience reports.

[38]  J. Kaplan,et al.  The molecular basis of iron overload disorders and iron-linked anemias , 2011, International journal of hematology.

[39]  C. Bröcker,et al.  Multisubunit Tethering Complexes and Their Role in Membrane Fusion , 2010, Current Biology.

[40]  A. Munnich,et al.  Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA) , 2010, Annals of Neurology.

[41]  S. Pfeffer,et al.  An update on transport vesicle tethering , 2010, Molecular membrane biology.

[42]  A. Wickrema,et al.  Vesicle trafficking plays a novel role in erythroblast enucleation. , 2010, Blood.

[43]  Daniel J. Klionsky,et al.  An Atg9-containing compartment that functions in the early steps of autophagosome biogenesis , 2010, The Journal of cell biology.

[44]  D. Rubinsztein,et al.  Autophagy, a guardian against neurodegeneration , 2010, Seminars in cell & developmental biology.

[45]  J. Hurley,et al.  Membrane budding and scission by the ESCRT machinery: it's all in the neck , 2010, Nature Reviews Molecular Cell Biology.

[46]  E. Englander,et al.  Accumulation of oxidative DNA damage in brain mitochondria in mouse model of hereditary ferritinopathy , 2010, Neuroscience Letters.

[47]  A. Foglia.  The acanthocyte-echinocyte differential: The example of chorea-acanthocytosis. , 2010, Swiss medical weekly.

[48]  N. Mohandas,et al.  Hereditary spherocytosis and hereditary elliptocytosis: aberrant protein sorting during erythroblast enucleation. , 2010, Blood.

[49]  Javier G. Magadán,et al.  Structural basis for the wobbler mouse neurodegenerative disorder caused by mutation in the Vps54 subunit of the GARP complex , 2010, Proceedings of the National Academy of Sciences.

[50]  J. Turk,et al.  Protection of pancreatic beta-cells by group VIA phospholipase A(2)-mediated repair of mitochondrial membrane peroxidation. , 2010, Endocrinology.

[51]  A. Cuervo,et al.  Autophagy gone awry in neurodegenerative diseases , 2010, Nature Neuroscience.

[52]  C. Rock,et al.  Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State , 2010, PloS one.

[53]  H. Hama.  Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. , 2010, Biochimica et biophysica acta.

[54]  N. Mohandas,et al.  Membrane remodeling during reticulocyte maturation. , 2010, Blood.

[55]  C. van Broeckhoven,et al.  Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations , 2010, Human molecular genetics.

[56]  B. Gallois,et al.  Mutant Ferritin L-chains That Cause Neurodegeneration Act in a Dominant-negative Manner to Reduce Ferritin Iron Incorporation* , 2010, The Journal of Biological Chemistry.

[57]  A. Pantaleo,et al.  Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. , 2010, Journal of proteomics.

[58]  S. Wakana,et al.  Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. , 2009, The American journal of pathology.

[59]  T. Hurley,et al.  Unraveling of the E-helices and Disruption of 4-Fold Pores Are Associated with Iron Mishandling in a Mutant Ferritin Causing Neurodegeneration* , 2009, The Journal of Biological Chemistry.

[60]  Bing Zhou,et al.  Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model. , 2009, Human molecular genetics.

[61]  F. Reggiori,et al.  Regulation of autophagy in yeast Saccharomyces cerevisiae. , 2009, Biochimica et biophysica acta.

[62]  Keiji Tanaka,et al.  The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. , 2009, Biochimica et biophysica acta.

[63]  M. Golub,et al.  Changes in red cell ion transport, reduced intratumoral neovascularization, and some mild motor function abnormalities accompany targeted disruption of the Mouse Kell gene (Kel) , 2009, American journal of hematology.

[64]  J. Cleveland,et al.  Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation. , 2009, Blood.

[65]  B. Ghetti,et al.  Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene , 2009, Journal of neurochemistry.

[66]  Qing Jun Wang,et al.  Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1–phosphatidylinositol-3-kinase complex , 2009, Nature Cell Biology.

[67]  S. Emr,et al.  ESCRTs and human disease. , 2009, Biochemical Society transactions.

[68]  Z. Harris,et al.  Ceruloplasmin in neurodegenerative diseases. , 2008, Biochemical Society transactions.

[69]  N. Mohandas,et al.  Red cell membrane: past, present, and future. , 2008, Blood.

[70]  S. Emr,et al.  Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface , 2008, Cell.

[71]  M. Baraibar,et al.  Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration , 2008, Journal of Biological Chemistry.

[72]  A. Gregory,et al.  Clinical and genetic delineation of neurodegeneration with brain iron accumulation , 2008, Journal of Medical Genetics.

[73]  S. Perrotta,et al.  PTPϵ has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells , 2008, Proteomics.

[74]  E. Bertini,et al.  Neurodegeneration associated with genetic defects in phospholipase A2 , 2008, Neurology.

[75]  D. Hartmann,et al.  Absence of 2-Hydroxylated Sphingolipids Is Compatible with Normal Neural Development But Causes Late-Onset Axon and Myelin Sheath Degeneration , 2008, The Journal of Neuroscience.

[76]  James B. Mitchell,et al.  Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice , 2008, Proceedings of the National Academy of Sciences.

[77]  H. Shang,et al.  The Neurological Presentation of Ceruloplasmin Gene Mutations , 2008, European Neurology.

[78]  H. Sandoval,et al.  Essential role for Nix in autophagic maturation of erythroid cells , 2008, Nature.

[79]  H. Kampinga,et al.  De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system. , 2008, Human molecular genetics.

[80]  D. Hernandez,et al.  Characterization of PLA2G6 as a locus for dystonia‐parkinsonism , 2008, Annals of neurology.

[81]  J. Bonifacino,et al.  Requirement of the human GARP complex for mannose 6-phosphate-receptor-dependent sorting of cathepsin D to lysosomes. , 2008, Molecular biology of the cell.

[82]  D. Birchall,et al.  T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation , 2008, Neurology.

[83]  D. Ginty,et al.  Endothelins are vascular-derived axonal guidance cues for developing sympathetic neurons , 2008, Nature.

[84]  C. Ross,et al.  A Comparison of Huntington Disease and Huntington Disease-Like 2 Neuropathology , 2008, Journal of neuropathology and experimental neurology.

[85]  B. Ghetti,et al.  Expression of a Mutant Form of the Ferritin Light Chain Gene Induces Neurodegeneration and Iron Overload in Transgenic Mice , 2008, The Journal of Neuroscience.

[86]  S. Tapscott,et al.  An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. , 2007, Human molecular genetics.

[87]  F. Heppner,et al.  McLeod myopathy revisted – More neurogenic and less benign , 2007, Clinical Neurophysiology.

[88]  S. Emr,et al.  ESCRTing proteins in the endocytic pathway. , 2007, Trends in biochemical sciences.

[89]  C. Rock,et al.  Localization and regulation of mouse pantothenate kinase 2 , 2007, FEBS letters.

[90]  Masaaki Komatsu,et al.  Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration , 2007, Proceedings of the National Academy of Sciences.

[91]  R. Richards,et al.  Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. , 2007, Human molecular genetics.

[92]  A. Danek,et al.  McLeod syndrome: a neurohaematological disorder , 2007, Vox sanguinis.

[93]  Soohee Lee.  The value of DNA analysis for antigens of the Kell and Kx blood group systems , 2007, Transfusion.

[94]  G. Musci,et al.  Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI‐ceruloplasmin , 2007, The EMBO journal.

[95]  S. Trottier,et al.  The Kell and XK proteins of the Kell blood group are not co-expressed in the central nervous system , 2007, Brain Research.

[96]  Jim Mintz,et al.  Myelin Breakdown and Iron Changes in Huntington’s Disease: Pathogenesis and Treatment Implications , 2007, Neurochemical Research.

[97]  Soohee Lee,et al.  Expression Profiles of Mouse Kell, XK, and XPLAC mRNA , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[98]  C. Ross,et al.  Huntington's disease–like 2 is associated with CUG repeat‐containing RNA foci , 2007, Annals of neurology.

[99]  C. Rock,et al.  Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. , 2007, Chemistry & biology.

[100]  S. Izumo,et al.  In vivo distribution and localization of chorein. , 2007, Biochemical and biophysical research communications.

[101]  C. Rock,et al.  Activation of human mitochondrial pantothenate kinase 2 by palmitoylcarnitine , 2007, Proceedings of the National Academy of Sciences.

[102]  Edward A Dennis,et al.  The phospholipase A2 superfamily and its group numbering system. , 2006, Biochimica et biophysica acta.

[103]  M. E. Jacobs,et al.  The Tetrahymena thermophila Phagosome Proteome , 2006, Eukaryotic Cell.

[104]  Zhongming Ma,et al.  Calcium-independent Phospholipase A2 Localizes in and Protects Mitochondria during Apoptotic Induction by Staurosporine* , 2006, Journal of Biological Chemistry.

[105]  T. Rouault.  The role of iron regulatory proteins in mammalian iron homeostasis and disease , 2006, Nature chemical biology.

[106]  T. Ebner,et al.  Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8 , 2006, Nature Genetics.

[107]  Colin A. Johnson,et al.  PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron , 2006, Nature Genetics.

[108]  G. Debnath,et al.  Phosphatidylinositol-4,5-biphosphate (PIP2) differentially regulates the interaction of human erythrocyte protein 4.1 (4.1R) with membrane proteins. , 2006, Biochemistry.

[109]  T. Meitinger,et al.  Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation , 2006, Annals of neurology.

[110]  S. Tapscott,et al.  Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. , 2005, Molecular cell.

[111]  V. Vassiliev,et al.  Ceruloplasmin in neurodegenerative diseases , 2005, Brain Research Reviews.

[112]  A. Lengeling,et al.  Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse , 2005, Nature Genetics.

[113]  Soma Das,et al.  Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). , 2005, American journal of ophthalmology.

[114]  G. Debnath,et al.  Identification and Functional Characterization of Protein 4.1R and Actin-Binding Sites in Erythrocyte β Spectrin: Regulation of the Interactions by Phosphatidylinositol-4,5-bisphosphate† , 2005 .

[115]  A. Monaco,et al.  Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis , 2005, Neurogenetics.

[116]  M. T. Pellecchia,et al.  The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration , 2005, Neurology.

[117]  V. Gieselmann,et al.  A mammalian fatty acid hydroxylase responsible for the formation of alpha-hydroxylated galactosylceramide in myelin. , 2005, The Biochemical journal.

[118]  Rabi Tawil,et al.  Hereditary ferritinopathy: a novel mutation, its cellular pathology, and pathogenetic insights. , 2005, Journal of neuropathology and experimental neurology.

[119]  C. Rock,et al.  Coenzyme A: back in action. , 2005, Progress in lipid research.

[120]  Daisuke Sato,et al.  A gene‐targeted mouse model for chorea‐acanthocytosis , 2005, Journal of neurochemistry.

[121]  J. Trojanowski,et al.  Altered Neuronal Mitochondrial Coenzyme A Synthesis in Neurodegeneration with Brain Iron Accumulation Caused by Abnormal Processing, Stability, and Catalytic Activity of Mutant Pantothenate Kinase 2 , 2005, The Journal of Neuroscience.

[122]  A. Bielawska,et al.  The Human FA2H Gene Encodes a Fatty Acid 2-Hydroxylase* , 2004, Journal of Biological Chemistry.

[123]  J. Mysore,et al.  Huntington's disease–like 2 (HDL2) in North America and Japan , 2004, Annals of neurology.

[124]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[125]  A. Monaco,et al.  Analysis of the human VPS13 gene family. , 2004, Genomics.

[126]  A. Monaco,et al.  Chorein detection for the diagnosis of chorea‐acanthocytosis , 2004, Annals of neurology.

[127]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[128]  O. Rascol,et al.  Intracellular Ferritin Accumulation in Neural and Extraneural Tissue Characterizes a Neurodegenerative Disease Associated with a Mutation in the Ferritin Light Polypeptide Gene , 2004, Journal of neuropathology and experimental neurology.

[129]  Michael W. Salter,et al.  Src kinases: a hub for NMDA receptor regulation , 2004, Nature Reviews Neuroscience.

[130]  E. Cadenas.  Mitochondrial free radical production and cell signaling. , 2004, Molecular aspects of medicine.

[131]  H. Miyajima.  Aceruloplasminemia, an iron metabolic disorder , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[132]  J. Connor,et al.  Iron status and neural functioning. , 2003, Annual review of nutrition.

[133]  T. Ashizawa,et al.  Huntington’s disease–like 2 can present as chorea-acanthocytosis , 2003, Neurology.

[134]  J. Clayton-Smith,et al.  Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. , 2003, American journal of human genetics.

[135]  K. Mikoshiba,et al.  Impairment of N-methyl-d-aspartate receptor-controlled motor activity in LYN-deficient mice , 2003, Neuroscience.

[136]  T. Meitinger,et al.  An isoform of hPANK2, deficient in pantothenate kinase-associated neurodegeneration, localizes to mitochondria. , 2003, Human molecular genetics.

[137]  B. Levinson,et al.  Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. , 2003, The New England journal of medicine.

[138]  A. Monaco,et al.  Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis , 2002, European Journal of Human Genetics.

[139]  G. Di Iorio,et al.  Abnormal Accumulation of tTGase Products in Muscle and Erythrocytes of Chorea‐Acanthocytosis Patients , 2002, Journal of neuropathology and experimental neurology.

[140]  Jean-Pierre Julien,et al.  Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical Injury , 2002, The Journal of Neuroscience.

[141]  M. Brin,et al.  Autosomal dominant chorea–acanthocytosis with polyglutamine-containing neuronal inclusions , 2002, Neurology.

[142]  R. Gottlieb,et al.  Inhibition of mitochondrial calcium-independent phospholipase A2 (iPLA2) attenuates mitochondrial phospholipid loss and is cardioprotective. , 2002, The Biochemical journal.

[143]  N. Mohandas,et al.  Identification of a functional role for lipid asymmetry in biological membranes: Phosphatidylserine-skeletal protein interactions modulate membrane stability , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[144]  A. Monaco,et al.  McLeod neuroacanthocytosis: Genotype and phenotype , 2001, Annals of neurology.

[145]  V. Willour,et al.  A disorder similar to Huntington's disease is associated with a novel CAG repeat expansion , 2001, Annals of neurology.

[146]  A. Monaco,et al.  The chorea of McLeod syndrome , 2001, Movement disorders : official journal of the Movement Disorder Society.

[147]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[148]  M. Telen,et al.  Molecular Defects Underlying the Kell Null Phenotype* , 2001, The Journal of Biological Chemistry.

[149]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[150]  Y. Maruki,et al.  The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis , 2001, Nature Genetics.

[151]  Adrian Danek,et al.  A conserved sorting-associated protein is mutant in chorea-acanthocytosis , 2001, Nature Genetics.

[152]  P. Gönczy,et al.  fumble encodes a pantothenate kinase homolog required for proper mitosis and meiosis in Drosophila melanogaster. , 2001, Genetics.

[153]  Kazuhiro Iwai,et al.  Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice , 2001, Nature Genetics.

[154]  M. MacDonald,et al.  Huntingtin: an iron-regulated protein essential for normal nuclear and perinuclear organelles. , 2000, Human molecular genetics.

[155]  J. Balsinde,et al.  Calcium-independent phospholipase A(2): structure and function. , 2000, Biochimica et biophysica acta.

[156]  M. Iino,et al.  Junctophilins: a novel family of junctional membrane complex proteins. , 2000, Molecular cell.

[157]  Soohee Lee,et al.  Expression of Kell blood group protein in nonerythroid tissues. , 2000, Blood.

[158]  A. Nakamura,et al.  Increased lipid peroxidation in the brains of aceruloplasminemia patients , 2000, Journal of the Neurological Sciences.

[159]  Soohee Lee,et al.  The Kell blood group system: Kell and XK membrane proteins. , 2000, Seminars in hematology.

[160]  H. Horvitz,et al.  The ced-8 gene controls the timing of programmed cell deaths in C. elegans. , 2000, Molecular cell.

[161]  P. Gane,et al.  Analysis of deletions in three McLeod patients: exclusion of the XS locus from the Xp21.1-Xp21.2 region. , 2000, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[162]  W. Brück,et al.  Endothelin B receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus , 1999, Neuroscience.

[163]  J. Gitlin,et al.  Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[164]  A. Mele,et al.  Proteolytic processing of big endothelin-3 by the kell blood group protein. , 1999, Blood.

[165]  R. Hayashi,et al.  Ultrastructural Changes of Erythrocyte Membrane Skeletons in Chorea-Acanthocytosis and McLeod Syndrome Revealed by the Quick-Freezing and Deep-Etching Method , 1999, Acta Haematologica.

[166]  V. Bonavita,et al.  Late appearance of acanthocytes during the course of chorea-acanthocytosis , 1999, Journal of the Neurological Sciences.

[167]  Soohee Lee,et al.  Association of XK and Kell Blood Group Proteins* , 1998, The Journal of Biological Chemistry.

[168]  J. Gitlin,et al.  Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. , 1998, The American journal of clinical nutrition.

[169]  J. Brickner,et al.  SOI1 Encodes a Novel, Conserved Protein That Promotes TGN–Endosomal Cycling of Kex2p and Other Membrane Proteins by Modulating the Function of Two TGN Localization Signals , 1997, The Journal of cell biology.

[170]  M Farrall,et al.  Chorea-acanthocytosis: genetic linkage to chromosome 9q21. , 1997, American journal of human genetics.

[171]  Soohee Lee.  Molecular Basis of Kell Blood Group Phenotypes , 1997, Vox sanguinis.

[172]  B. Brors,et al.  Mitochondrial fatty acid synthesis: a relic of endosymbiontic origin and a specialized means for respiration , 1997, FEBS letters.

[173]  J. Brickner,et al.  Allele-specific suppression of a defective trans-Golgi network (TGN) localization signal in Kex2p identifies three genes involved in localization of TGN transmembrane proteins , 1996, Molecular and cellular biology.

[174]  K. Dry,et al.  Analysis of three deletion breakpoints in Xp21.1 and the further localization of RP3. , 1996, Genomics.

[175]  P. Harrison,et al.  The ferritins: molecular properties, iron storage function and cellular regulation. , 1996, Biochimica et biophysica acta.

[176]  A. Monaco,et al.  A novel point mutation in the mcleod syndrome gene in neuroacanthocytosis , 1996, Annals of neurology.

[177]  J. Gitlin,et al.  Genetic and molecular basis for copper toxicity. , 1996, The American journal of clinical nutrition.

[178]  T. Lisowsky,et al.  Different respiratory-defective phenotypes of Neurospora crassa and Saccharomyces cerevisiae after inactivation of the gene encoding the mitochondrial acyl carrier protein , 1995, Current Genetics.

[179]  R. Leduc,et al.  Processing of proendothelin‐1 by human furin convertase , 1995, FEBS letters.

[180]  M. Horstink,et al.  Erythrocyte anion transporter and antibrain immunoreactivity in chorea-acanthocytosis. A contribution to etiology, genetics, and diagnosis , 1994, Brain Research Bulletin.

[181]  Adrian Danek,et al.  Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein , 1994, Cell.

[182]  M. Tanner,et al.  Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868-->Leu in the membrane domain of band 3. , 1993, The Biochemical journal.

[183]  T. Kanaseki,et al.  [Studies on the erythrocyte membrane skeleton in a patient with chorea-acanthocytosis--theoretical speculation on the mechanism of neurological involvement]. , 1992, No to shinkei = Brain and nerve.

[184]  Soohee Lee,et al.  Molecular cloning and primary structure of Kell blood group protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[185]  T. Feinberg,et al.  Diagnostic tests for choreoacanthocytosis , 1991, Neurology.

[186]  S Kimura,et al.  Terminal axon pathology in infantile neuroaxonal dystrophy. , 1991, Pediatric neurology.

[187]  J. AuBuchon,et al.  Abnormal membrane physical properties of red cells in McLeod syndrome , 1990, Transfusion.

[188]  H. Matsumoto,et al.  One of the endothelin gene family, endothelin 3 gene, is expressed in the placenta , 1990, FEBS letters.

[189]  B. Roelofsen,et al.  The phospholipid organisation in the membranes of McLeod and Leach phenotype erythrocytes , 1985, FEBS letters.

[190]  N. Yanagisawa,et al.  Erythrocyte membrane abnormalities in patients with amyotrophic chorea with acanthocythosis Part 2. Abnormal degradation of membrane proteins , 1985, Journal of the Neurological Sciences.

[191]  A. Moore,et al.  Elevated Serum Creatine Phosphokinase in Subjects with McLeod Syndrome , 1981, Vox sanguinis.

[192]  W. Galey,et al.  Haematological Changes Associated with the McLeod Phenotype of the Kell Blood Group System , 1977, British journal of haematology.

[193]  Y. Mizuno,et al.  An analysis of the ultrastructural findings in infantile neuroaxonal dystrophy (Seitelberger's disease) , 1974, Acta Neuropathologica.

[194]  E. Frieden,et al.  The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. , 1971, The Journal of biological chemistry.

[195]  S. Osaki.  Kinetic studies of ferrous ion oxidation with crystalline human ferroxidase (ceruloplasmin). , 1966, The Journal of biological chemistry.

[196]  E. Frieden,et al.  The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. , 1966, The Journal of biological chemistry.

[197]  諸石 寿朗.  The FBXL5-IRP2 axis is integral to control of iron metabolism in vivo , 2012 .

[198]  D. Tarsy,et al.  Huntington’s Disease-Like 2 , 2012 .

[199]  O. Sibon,et al.  The role of impaired de novo Coenzyme A biosynthesis in pantothenate kinase-associated neurodegeneration , 2011 .

[200]  D. Rubinsztein,et al.  Chemical modulators of autophagy as biological probes and potential therapeutics. , 2011, Nature chemical biology.

[201]  富安 昭之.  Novel pathogenic mutations and copy number variations in the VPS13A gene in patients with chorea-acanthocytosis , 2011 .

[202]  J. Lundeberg,et al.  The plasticity of the mammalian transcriptome. , 2010, Genomics.

[203]  R. Schmidt,et al.  Molecular Pathogenesis of Genetic and Inherited Diseases Disrupted Membrane Homeostasis and Accumulation of Ubiquitinated Proteins in a Mouse Model of Infantile Neuroaxonal Dystrophy Caused by PLA 2 G 6 Mutations , 2010 .

[204]  M. Borg,et al.  [Chorea-acanthocytosis without acanthocytes]. , 2010, Revue neurologique.

[205]  吉野 浩代.  Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism , 2010 .

[206]  A. Danek,et al.  Neuropathology of Chorea-Acanthocytosis , 2008 .

[207]  A. Monaco,et al.  The Function of Chorein , 2008 .

[208]  A. Danek,et al.  Dominant transmission of chorea-acanthocytosis with VPS13A mutations remains speculative , 2008, Acta Neuropathologica.

[209]  S. Saiki,et al.  A neuropathological study of autosomal-dominant chorea-acanthocytosis with a mutation of VPS13A , 2008, Acta Neuropathologica.

[210]  K. Leenders,et al.  NEUROACANTHOCYTOSIS SYNDROMES II , 2008 .

[211]  倉野 裕.  Chorein deficiency leads to upregulation of gephyrin and GABA[A] receptor , 2007 .

[212]  H. Miyajima,et al.  Molecular and pathological basis of aceruloplasminemia. , 2006, Biological research.

[213]  J. Duncan,et al.  Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. , 2005, Human molecular genetics.

[214]  A. Storch,et al.  Testing for acanthocytosis A prospective reader-blinded study in movement disorder patients. , 2005, Journal of neurology.

[215]  M. Elstner,et al.  Acanthocytes in Pantothenate Kinase Associated Neurodegeneration , 2004 .

[216]  J. Grafman,et al.  Cognitive and Neuropsychiatric Findings in McLeod Syndrome and in Chorea-Acanthocytosis , 2004 .

[217]  C. Ross,et al.  A repeat expansion in the gene encoding junctophilin-3 is associated with Huntington disease–like 2 , 2001, Nature Genetics.

[218]  Marie Lin,et al.  Molecular Basis of the Kell-null Phenotype A MUTATION AT THE SPLICE SITE OF HUMAN KEL GENE ABOLISHES THE EXPRESSION OF KELL BLOOD GROUP ANTIGENS* , 2001 .

[219]  O. Olivieri,et al.  Increased membrane protein phosphorylation and anion transport activity in chorea-acanthocytosis. , 1997, Haematologica.

[220]  Peter Beighton,et al.  de la Chapelle, A. , 1997 .

[221]  A. Sevanian,et al.  Lipid peroxidation-induced membrane structural alterations. , 1994, Methods in enzymology.

[222]  M. Kay,et al.  Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.